Microsoft WordDOCX

First Page		Document Content
Date: 2016-08-03 18:48:38 Antiandrogens Chemistry Clinical medicine Enzyme inhibitors Cancer Prostate cancer Organofluorides Galeterone Steroids Enzalutamide Abiraterone acetate Medivation		Microsoft WordDOCX Add to Reading List Source URL: securities.stanford.edu Download Document from Source Website File Size: 234,17 KB Share Document on Facebook

	Microsoft WordDOCX DocID: 1rnqZ - View Document
	Award ID: CP130020 Project Title: Androgen Receptor N-Terminus Blocker Program for Prostate Cancer Award Mechanism: Company Relocation DocID: 19pfm - View Document
	September 10, 2012 Astex Pharmaceuticals Announces Initiation of HSP90 Inhibitor AT13387 Clinical Trial in Prostate Cancer Patients DUBLIN, Calif., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq: DocID: 11qq3 - View Document
	Microsoft PowerPointGU Disease Site Schema Flowsheet.pptx DocID: W9oO - View Document
	R&D Pipeline (October[removed]Global Development (1) Approval / Labeling Revision #Compounds with "In-house" in this column include one discovered by collaborative research. (The same applicable hereafter.) Code No. Gen DocID: IFu7 - View Document